Horizon partners with big pharma company on CRISPR
29-08-2018
EPO grants second CRISPR patent to ERS Genomics
07-03-2018
CRISPR in Europe: the patent landscape for 2018
30-11-2017
Horizon Discovery expands CRISPR licence
17-01-2017
UK-based genomics company Horizon Discovery has expanded its licence coverage for use of the CRISPR gene-editing technology.
To continue reading this article and to access our full archive, digital magazines and special reports you will need a subscription.
Start a subscription today to access the LSIPR website
If you have already subscribed please login.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Atif at achoudhury@newtonmedia.co.uk
If you have any technical issues please email tech support.
For access to the complete website and archive choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial select ‘TWO WEEK FREE TRIAL’.
Horizon Discovery, genetics, gene editing, ERS Genomics, licence, CRISPR, technology
